nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR1A—stomach cancer	0.74	1	CbGaD
Molindone—HTR7—myenteric nerve plexus—stomach cancer	0.0193	0.184	CbGeAlD
Molindone—HTR7—vagus nerve—stomach cancer	0.0129	0.123	CbGeAlD
Molindone—HTR7—vein—stomach cancer	0.0124	0.119	CbGeAlD
Molindone—HTR2A—myenteric nerve plexus—stomach cancer	0.012	0.115	CbGeAlD
Molindone—HTR2A—vagus nerve—stomach cancer	0.00803	0.0766	CbGeAlD
Molindone—HTR2A—vein—stomach cancer	0.00776	0.074	CbGeAlD
Molindone—HTR7—blood vessel—stomach cancer	0.00395	0.0377	CbGeAlD
Molindone—Salivation—Irinotecan—stomach cancer	0.0029	0.0503	CcSEcCtD
Molindone—Euphoric mood—Floxuridine—stomach cancer	0.00284	0.0491	CcSEcCtD
Molindone—HTR2A—blood vessel—stomach cancer	0.00246	0.0235	CbGeAlD
Molindone—Pigmentation disorder—Capecitabine—stomach cancer	0.00226	0.0391	CcSEcCtD
Molindone—HTR1A—hematopoietic system—stomach cancer	0.0022	0.021	CbGeAlD
Molindone—HTR7—hematopoietic system—stomach cancer	0.0021	0.0201	CbGeAlD
Molindone—Akathisia—Irinotecan—stomach cancer	0.00203	0.0352	CcSEcCtD
Molindone—HTR7—epithelium—stomach cancer	0.00192	0.0183	CbGeAlD
Molindone—HTR7—smooth muscle tissue—stomach cancer	0.00185	0.0177	CbGeAlD
Molindone—Pigmentation disorder—Epirubicin—stomach cancer	0.00157	0.0272	CcSEcCtD
Molindone—ADRA2A—hematopoietic system—stomach cancer	0.00154	0.0147	CbGeAlD
Molindone—HTR7—digestive system—stomach cancer	0.00146	0.0139	CbGeAlD
Molindone—Pigmentation disorder—Doxorubicin—stomach cancer	0.00146	0.0252	CcSEcCtD
Molindone—Drowsiness—Mitomycin—stomach cancer	0.00145	0.0251	CcSEcCtD
Molindone—CHRM1—endocrine gland—stomach cancer	0.00142	0.0135	CbGeAlD
Molindone—Muscle spasms—Floxuridine—stomach cancer	0.00139	0.024	CcSEcCtD
Molindone—HTR2A—hematopoietic system—stomach cancer	0.00131	0.0125	CbGeAlD
Molindone—Leukopenia—Floxuridine—stomach cancer	0.00129	0.0224	CcSEcCtD
Molindone—HTR1A—endocrine gland—stomach cancer	0.00126	0.0121	CbGeAlD
Molindone—ADRA2A—pancreas—stomach cancer	0.00126	0.012	CbGeAlD
Molindone—HTR7—endocrine gland—stomach cancer	0.00121	0.0115	CbGeAlD
Molindone—HTR2A—epithelium—stomach cancer	0.0012	0.0114	CbGeAlD
Molindone—HTR2A—smooth muscle tissue—stomach cancer	0.00115	0.011	CbGeAlD
Molindone—Leukocytosis—Fluorouracil—stomach cancer	0.00115	0.0199	CcSEcCtD
Molindone—DRD2—endocrine gland—stomach cancer	0.00114	0.0109	CbGeAlD
Molindone—Salivary hypersecretion—Irinotecan—stomach cancer	0.00109	0.0189	CcSEcCtD
Molindone—HTR7—liver—stomach cancer	0.00109	0.0104	CbGeAlD
Molindone—Vision blurred—Mitomycin—stomach cancer	0.00107	0.0185	CcSEcCtD
Molindone—Leukopenia—Mitomycin—stomach cancer	0.00101	0.0176	CcSEcCtD
Molindone—Euphoric mood—Fluorouracil—stomach cancer	0.000927	0.016	CcSEcCtD
Molindone—HTR2A—digestive system—stomach cancer	0.000911	0.0087	CbGeAlD
Molindone—Amenorrhoea—Docetaxel—stomach cancer	0.000886	0.0153	CcSEcCtD
Molindone—ADRA2A—endocrine gland—stomach cancer	0.000886	0.00845	CbGeAlD
Molindone—Dyspnoea—Mitomycin—stomach cancer	0.000825	0.0143	CcSEcCtD
Molindone—Somnolence—Mitomycin—stomach cancer	0.000822	0.0142	CcSEcCtD
Molindone—HTR2A—endocrine gland—stomach cancer	0.000753	0.00719	CbGeAlD
Molindone—Rash—Floxuridine—stomach cancer	0.000743	0.0129	CcSEcCtD
Molindone—Dermatitis—Floxuridine—stomach cancer	0.000743	0.0128	CcSEcCtD
Molindone—Nausea—Floxuridine—stomach cancer	0.0007	0.0121	CcSEcCtD
Molindone—HTR2A—liver—stomach cancer	0.000679	0.00648	CbGeAlD
Molindone—Dysphagia—Fluorouracil—stomach cancer	0.000677	0.0117	CcSEcCtD
Molindone—Weight decreased—Irinotecan—stomach cancer	0.000639	0.0111	CcSEcCtD
Molindone—ADRA2A—lymph node—stomach cancer	0.000612	0.00584	CbGeAlD
Molindone—Amenorrhoea—Epirubicin—stomach cancer	0.000598	0.0103	CcSEcCtD
Molindone—Rash—Mitomycin—stomach cancer	0.000583	0.0101	CcSEcCtD
Molindone—Dermatitis—Mitomycin—stomach cancer	0.000583	0.0101	CcSEcCtD
Molindone—Dyskinesia—Epirubicin—stomach cancer	0.000559	0.00967	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—stomach cancer	0.000553	0.00957	CcSEcCtD
Molindone—Nausea—Mitomycin—stomach cancer	0.000549	0.00951	CcSEcCtD
Molindone—Disturbance in sexual arousal—Capecitabine—stomach cancer	0.000543	0.00939	CcSEcCtD
Molindone—Urinary retention—Capecitabine—stomach cancer	0.00052	0.009	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—stomach cancer	0.000517	0.00894	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—stomach cancer	0.00051	0.00882	CcSEcCtD
Molindone—Gynaecomastia—Methotrexate—stomach cancer	0.000502	0.00869	CcSEcCtD
Molindone—Dysphagia—Docetaxel—stomach cancer	0.000488	0.00845	CcSEcCtD
Molindone—Muscle spasms—Irinotecan—stomach cancer	0.000473	0.00819	CcSEcCtD
Molindone—Dysphagia—Capecitabine—stomach cancer	0.000473	0.00818	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—stomach cancer	0.000472	0.00816	CcSEcCtD
Molindone—Weight increased—Docetaxel—stomach cancer	0.000444	0.00769	CcSEcCtD
Molindone—Vision blurred—Fluorouracil—stomach cancer	0.000444	0.00769	CcSEcCtD
Molindone—Weight decreased—Docetaxel—stomach cancer	0.000442	0.00765	CcSEcCtD
Molindone—Leukopenia—Irinotecan—stomach cancer	0.000441	0.00762	CcSEcCtD
Molindone—Weight increased—Capecitabine—stomach cancer	0.00043	0.00745	CcSEcCtD
Molindone—Weight decreased—Capecitabine—stomach cancer	0.000428	0.0074	CcSEcCtD
Molindone—Leukopenia—Fluorouracil—stomach cancer	0.000422	0.0073	CcSEcCtD
Molindone—Tachycardia—Fluorouracil—stomach cancer	0.000376	0.0065	CcSEcCtD
Molindone—Hypotension—Irinotecan—stomach cancer	0.000375	0.0065	CcSEcCtD
Molindone—Hypotension—Fluorouracil—stomach cancer	0.00036	0.00622	CcSEcCtD
Molindone—Dyspnoea—Irinotecan—stomach cancer	0.000358	0.0062	CcSEcCtD
Molindone—Somnolence—Irinotecan—stomach cancer	0.000357	0.00618	CcSEcCtD
Molindone—Constipation—Irinotecan—stomach cancer	0.000344	0.00594	CcSEcCtD
Molindone—Dyspnoea—Fluorouracil—stomach cancer	0.000343	0.00594	CcSEcCtD
Molindone—Somnolence—Fluorouracil—stomach cancer	0.000342	0.00592	CcSEcCtD
Molindone—Dysphagia—Epirubicin—stomach cancer	0.000329	0.0057	CcSEcCtD
Molindone—Muscle spasms—Docetaxel—stomach cancer	0.000327	0.00566	CcSEcCtD
Molindone—Muscle spasms—Capecitabine—stomach cancer	0.000317	0.00548	CcSEcCtD
Molindone—Drowsiness—Methotrexate—stomach cancer	0.000314	0.00543	CcSEcCtD
Molindone—Vision blurred—Capecitabine—stomach cancer	0.000311	0.00537	CcSEcCtD
Molindone—Tremor—Capecitabine—stomach cancer	0.000309	0.00534	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—stomach cancer	0.000305	0.00527	CcSEcCtD
Molindone—Leukopenia—Docetaxel—stomach cancer	0.000305	0.00527	CcSEcCtD
Molindone—Weight increased—Epirubicin—stomach cancer	0.0003	0.00519	CcSEcCtD
Molindone—Weight decreased—Epirubicin—stomach cancer	0.000298	0.00516	CcSEcCtD
Molindone—Leukopenia—Capecitabine—stomach cancer	0.000295	0.0051	CcSEcCtD
Molindone—Drowsiness—Epirubicin—stomach cancer	0.000294	0.00508	CcSEcCtD
Molindone—Dry mouth—Docetaxel—stomach cancer	0.000283	0.0049	CcSEcCtD
Molindone—Weight increased—Doxorubicin—stomach cancer	0.000277	0.0048	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—stomach cancer	0.000276	0.00477	CcSEcCtD
Molindone—Dry mouth—Capecitabine—stomach cancer	0.000274	0.00475	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—stomach cancer	0.000272	0.0047	CcSEcCtD
Molindone—Tachycardia—Docetaxel—stomach cancer	0.000271	0.00469	CcSEcCtD
Molindone—Tachycardia—Capecitabine—stomach cancer	0.000262	0.00454	CcSEcCtD
Molindone—Hypotension—Docetaxel—stomach cancer	0.00026	0.00449	CcSEcCtD
Molindone—Rash—Irinotecan—stomach cancer	0.000253	0.00438	CcSEcCtD
Molindone—Dermatitis—Irinotecan—stomach cancer	0.000253	0.00438	CcSEcCtD
Molindone—Hypotension—Capecitabine—stomach cancer	0.000251	0.00435	CcSEcCtD
Molindone—Dyspnoea—Docetaxel—stomach cancer	0.000248	0.00428	CcSEcCtD
Molindone—Somnolence—Docetaxel—stomach cancer	0.000247	0.00427	CcSEcCtD
Molindone—Rash—Fluorouracil—stomach cancer	0.000243	0.0042	CcSEcCtD
Molindone—Dermatitis—Fluorouracil—stomach cancer	0.000242	0.00419	CcSEcCtD
Molindone—Dyspnoea—Capecitabine—stomach cancer	0.00024	0.00415	CcSEcCtD
Molindone—Nausea—Irinotecan—stomach cancer	0.000239	0.00413	CcSEcCtD
Molindone—Constipation—Docetaxel—stomach cancer	0.000237	0.00411	CcSEcCtD
Molindone—Vision blurred—Methotrexate—stomach cancer	0.000231	0.004	CcSEcCtD
Molindone—Constipation—Capecitabine—stomach cancer	0.00023	0.00398	CcSEcCtD
Molindone—Nausea—Fluorouracil—stomach cancer	0.000229	0.00395	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—stomach cancer	0.000221	0.00382	CcSEcCtD
Molindone—Leukopenia—Methotrexate—stomach cancer	0.00022	0.0038	CcSEcCtD
Molindone—Vision blurred—Epirubicin—stomach cancer	0.000216	0.00374	CcSEcCtD
Molindone—Agitation—Epirubicin—stomach cancer	0.000211	0.00365	CcSEcCtD
Molindone—Leukopenia—Epirubicin—stomach cancer	0.000205	0.00355	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—stomach cancer	0.000204	0.00353	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—stomach cancer	0.0002	0.00346	CcSEcCtD
Molindone—Agitation—Doxorubicin—stomach cancer	0.000195	0.00338	CcSEcCtD
Molindone—Dry mouth—Epirubicin—stomach cancer	0.000191	0.00331	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—stomach cancer	0.00019	0.00329	CcSEcCtD
Molindone—Hypotension—Methotrexate—stomach cancer	0.000187	0.00324	CcSEcCtD
Molindone—Tachycardia—Epirubicin—stomach cancer	0.000183	0.00316	CcSEcCtD
Molindone—Dyspnoea—Methotrexate—stomach cancer	0.000178	0.00309	CcSEcCtD
Molindone—Somnolence—Methotrexate—stomach cancer	0.000178	0.00308	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—stomach cancer	0.000177	0.00306	CcSEcCtD
Molindone—Rash—Docetaxel—stomach cancer	0.000175	0.00303	CcSEcCtD
Molindone—Hypotension—Epirubicin—stomach cancer	0.000175	0.00303	CcSEcCtD
Molindone—Dermatitis—Docetaxel—stomach cancer	0.000175	0.00303	CcSEcCtD
Molindone—Rash—Capecitabine—stomach cancer	0.00017	0.00293	CcSEcCtD
Molindone—Dermatitis—Capecitabine—stomach cancer	0.000169	0.00293	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—stomach cancer	0.000169	0.00293	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—stomach cancer	0.000167	0.00289	CcSEcCtD
Molindone—Somnolence—Epirubicin—stomach cancer	0.000167	0.00288	CcSEcCtD
Molindone—Nausea—Docetaxel—stomach cancer	0.000165	0.00285	CcSEcCtD
Molindone—Hypotension—Doxorubicin—stomach cancer	0.000162	0.0028	CcSEcCtD
Molindone—Constipation—Epirubicin—stomach cancer	0.00016	0.00277	CcSEcCtD
Molindone—Nausea—Capecitabine—stomach cancer	0.00016	0.00276	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—stomach cancer	0.000155	0.00267	CcSEcCtD
Molindone—Somnolence—Doxorubicin—stomach cancer	0.000154	0.00267	CcSEcCtD
Molindone—Constipation—Doxorubicin—stomach cancer	0.000148	0.00256	CcSEcCtD
Molindone—Rash—Methotrexate—stomach cancer	0.000126	0.00218	CcSEcCtD
Molindone—Dermatitis—Methotrexate—stomach cancer	0.000126	0.00218	CcSEcCtD
Molindone—Nausea—Methotrexate—stomach cancer	0.000119	0.00206	CcSEcCtD
Molindone—Rash—Epirubicin—stomach cancer	0.000118	0.00204	CcSEcCtD
Molindone—Dermatitis—Epirubicin—stomach cancer	0.000118	0.00204	CcSEcCtD
Molindone—Nausea—Epirubicin—stomach cancer	0.000111	0.00193	CcSEcCtD
Molindone—Rash—Doxorubicin—stomach cancer	0.000109	0.00189	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—stomach cancer	0.000109	0.00189	CcSEcCtD
Molindone—Nausea—Doxorubicin—stomach cancer	0.000103	0.00178	CcSEcCtD
Molindone—HTR2A—Signaling by GPCR—RHOA—stomach cancer	1.59e-05	0.000163	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—RHOA—stomach cancer	1.58e-05	0.000162	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SMAD4—stomach cancer	1.58e-05	0.000162	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	1.56e-05	0.00016	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SMAD4—stomach cancer	1.55e-05	0.00016	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	1.55e-05	0.00016	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SMAD4—stomach cancer	1.54e-05	0.000159	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ERCC2—stomach cancer	1.54e-05	0.000158	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CXCL8—stomach cancer	1.53e-05	0.000158	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	1.53e-05	0.000157	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—KRAS—stomach cancer	1.53e-05	0.000157	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—PIK3CA—stomach cancer	1.52e-05	0.000156	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	1.52e-05	0.000156	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—SERPINE1—stomach cancer	1.52e-05	0.000156	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—KRAS—stomach cancer	1.5e-05	0.000155	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FYN—stomach cancer	1.5e-05	0.000154	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FYN—stomach cancer	1.47e-05	0.000152	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IRS2—stomach cancer	1.47e-05	0.000151	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—RHOA—stomach cancer	1.47e-05	0.000151	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FYN—stomach cancer	1.47e-05	0.000151	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NOS3—stomach cancer	1.45e-05	0.000149	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—MTHFR—stomach cancer	1.45e-05	0.000149	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	1.44e-05	0.000149	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CAV1—stomach cancer	1.42e-05	0.000146	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APOA1—stomach cancer	1.42e-05	0.000146	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CXCL8—stomach cancer	1.42e-05	0.000146	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	1.41e-05	0.000145	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FGFR2—stomach cancer	1.41e-05	0.000145	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—PIK3CA—stomach cancer	1.4e-05	0.000144	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	1.4e-05	0.000144	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CXCL8—stomach cancer	1.39e-05	0.000143	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	1.39e-05	0.000143	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FGFR2—stomach cancer	1.38e-05	0.000142	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—PIK3CA—stomach cancer	1.38e-05	0.000142	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FGFR2—stomach cancer	1.38e-05	0.000141	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—ERBB2—stomach cancer	1.36e-05	0.00014	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—TP53—stomach cancer	1.36e-05	0.000139	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PRKCB—stomach cancer	1.35e-05	0.000139	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6ST—stomach cancer	1.35e-05	0.000139	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FYN—stomach cancer	1.34e-05	0.000138	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CAV1—stomach cancer	1.34e-05	0.000137	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOA1—stomach cancer	1.33e-05	0.000137	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—HRAS—stomach cancer	1.3e-05	0.000133	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APC—stomach cancer	1.29e-05	0.000133	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IRS2—stomach cancer	1.29e-05	0.000132	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CXCL8—stomach cancer	1.29e-05	0.000132	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—HRAS—stomach cancer	1.28e-05	0.000131	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	1.27e-05	0.00013	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IRS2—stomach cancer	1.27e-05	0.00013	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IRS2—stomach cancer	1.26e-05	0.00013	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	1.26e-05	0.000129	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CDKN1B—stomach cancer	1.26e-05	0.000129	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CAV1—stomach cancer	1.25e-05	0.000128	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOA1—stomach cancer	1.24e-05	0.000128	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	1.24e-05	0.000128	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CAV1—stomach cancer	1.23e-05	0.000126	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOA1—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—IL6—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CAV1—stomach cancer	1.22e-05	0.000126	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOA1—stomach cancer	1.22e-05	0.000125	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6R—stomach cancer	1.2e-05	0.000124	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCND1—stomach cancer	1.2e-05	0.000123	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—JUN—stomach cancer	1.2e-05	0.000123	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PRKCB—stomach cancer	1.19e-05	0.000122	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6ST—stomach cancer	1.18e-05	0.000122	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	1.18e-05	0.000121	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—EGFR—stomach cancer	1.18e-05	0.000121	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPARG—stomach cancer	1.17e-05	0.000121	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PRKCB—stomach cancer	1.17e-05	0.00012	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6ST—stomach cancer	1.16e-05	0.00012	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MMP9—stomach cancer	1.16e-05	0.00012	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PRKCB—stomach cancer	1.16e-05	0.00012	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CDKN1A—stomach cancer	1.16e-05	0.000119	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6ST—stomach cancer	1.16e-05	0.000119	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IRS2—stomach cancer	1.15e-05	0.000118	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APC—stomach cancer	1.14e-05	0.000117	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK8—stomach cancer	1.13e-05	0.000116	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	1.13e-05	0.000116	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	1.13e-05	0.000116	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APC—stomach cancer	1.12e-05	0.000115	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CAV1—stomach cancer	1.12e-05	0.000115	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOA1—stomach cancer	1.11e-05	0.000115	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—KRAS—stomach cancer	1.11e-05	0.000115	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APC—stomach cancer	1.11e-05	0.000114	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK3—stomach cancer	1.09e-05	0.000112	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—RHOA—stomach cancer	1.09e-05	0.000112	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOS3—stomach cancer	1.07e-05	0.000111	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK3—stomach cancer	1.07e-05	0.00011	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	1.07e-05	0.00011	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	1.06e-05	0.000109	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	1.06e-05	0.000109	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—stomach cancer	1.06e-05	0.000109	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6R—stomach cancer	1.06e-05	0.000109	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—stomach cancer	1.04e-05	0.000107	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6R—stomach cancer	1.04e-05	0.000107	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK1—stomach cancer	1.04e-05	0.000107	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—EGFR—stomach cancer	1.04e-05	0.000107	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—stomach cancer	1.03e-05	0.000106	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6R—stomach cancer	1.03e-05	0.000106	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	1.02e-05	0.000105	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	1.02e-05	0.000105	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—EGFR—stomach cancer	1.02e-05	0.000105	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APC—stomach cancer	1.02e-05	0.000105	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	1.01e-05	0.000104	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—EGFR—stomach cancer	1.01e-05	0.000104	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—NOS3—stomach cancer	1.01e-05	0.000104	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ERBB2—stomach cancer	1.01e-05	0.000103	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	9.9e-06	0.000102	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK3—stomach cancer	9.88e-06	0.000102	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SERPINE1—stomach cancer	9.88e-06	0.000102	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—KRAS—stomach cancer	9.78e-06	0.000101	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	9.74e-06	0.0001	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	9.74e-06	0.0001	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	9.72e-06	0.0001	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	9.69e-06	9.96e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	9.67e-06	9.95e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—KRAS—stomach cancer	9.62e-06	9.9e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—stomach cancer	9.61e-06	9.89e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—KRAS—stomach cancer	9.57e-06	9.85e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—RHOA—stomach cancer	9.53e-06	9.81e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCL8—stomach cancer	9.53e-06	9.8e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HRAS—stomach cancer	9.47e-06	9.74e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6R—stomach cancer	9.45e-06	9.72e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOS3—stomach cancer	9.43e-06	9.7e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK1—stomach cancer	9.4e-06	9.67e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EGFR—stomach cancer	9.4e-06	9.67e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—RHOA—stomach cancer	9.38e-06	9.65e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—RHOA—stomach cancer	9.33e-06	9.6e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	9.31e-06	9.57e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOS3—stomach cancer	9.28e-06	9.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	9.27e-06	9.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	9.27e-06	9.53e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—stomach cancer	9.24e-06	9.5e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOS3—stomach cancer	9.23e-06	9.5e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—stomach cancer	9.06e-06	9.32e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	8.99e-06	9.24e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—KRAS—stomach cancer	8.88e-06	9.14e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCND1—stomach cancer	8.88e-06	9.13e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—JUN—stomach cancer	8.86e-06	9.12e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	8.86e-06	9.11e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	8.85e-06	9.1e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	8.84e-06	9.1e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ERBB2—stomach cancer	8.82e-06	9.08e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	8.8e-06	9.05e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	8.76e-06	9.01e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ERBB2—stomach cancer	8.68e-06	8.93e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ERBB2—stomach cancer	8.64e-06	8.88e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—stomach cancer	8.62e-06	8.87e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	8.59e-06	8.84e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RHOA—stomach cancer	8.53e-06	8.78e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOS3—stomach cancer	8.45e-06	8.69e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK8—stomach cancer	8.38e-06	8.62e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCL8—stomach cancer	8.37e-06	8.61e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HRAS—stomach cancer	8.31e-06	8.55e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCL8—stomach cancer	8.23e-06	8.47e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCL8—stomach cancer	8.19e-06	8.42e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—HRAS—stomach cancer	8.18e-06	8.42e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1B—stomach cancer	8.17e-06	8.41e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—stomach cancer	8.16e-06	8.39e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HRAS—stomach cancer	8.14e-06	8.37e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	8.04e-06	8.28e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	8.04e-06	8.27e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	8e-06	8.23e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—stomach cancer	7.96e-06	8.19e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	7.9e-06	8.13e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—stomach cancer	7.89e-06	8.12e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—stomach cancer	7.83e-06	8.05e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCND1—stomach cancer	7.8e-06	8.02e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—stomach cancer	7.79e-06	8.01e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—JUN—stomach cancer	7.78e-06	8e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—stomach cancer	7.74e-06	7.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCND1—stomach cancer	7.67e-06	7.89e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—stomach cancer	7.67e-06	7.88e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—JUN—stomach cancer	7.66e-06	7.87e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCND1—stomach cancer	7.63e-06	7.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—JUN—stomach cancer	7.61e-06	7.83e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—stomach cancer	7.57e-06	7.79e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HRAS—stomach cancer	7.55e-06	7.77e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1A—stomach cancer	7.54e-06	7.76e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	7.49e-06	7.71e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—stomach cancer	7.45e-06	7.66e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	7.44e-06	7.66e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	7.42e-06	7.63e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—stomach cancer	7.41e-06	7.62e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	7.38e-06	7.59e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK8—stomach cancer	7.36e-06	7.57e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK3—stomach cancer	7.32e-06	7.53e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	7.32e-06	7.53e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK8—stomach cancer	7.24e-06	7.45e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—stomach cancer	7.23e-06	7.43e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK8—stomach cancer	7.2e-06	7.41e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—stomach cancer	7.12e-06	7.33e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—stomach cancer	7.12e-06	7.33e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCND1—stomach cancer	6.98e-06	7.18e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK1—stomach cancer	6.97e-06	7.17e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EGFR—stomach cancer	6.97e-06	7.17e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—JUN—stomach cancer	6.96e-06	7.16e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—stomach cancer	6.8e-06	6.99e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—stomach cancer	6.78e-06	6.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	6.75e-06	6.95e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—stomach cancer	6.73e-06	6.92e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—stomach cancer	6.69e-06	6.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—stomach cancer	6.65e-06	6.84e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—stomach cancer	6.62e-06	6.81e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	6.59e-06	6.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—stomach cancer	6.59e-06	6.78e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KRAS—stomach cancer	6.58e-06	6.77e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK3—stomach cancer	6.43e-06	6.61e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK3—stomach cancer	6.33e-06	6.51e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK3—stomach cancer	6.29e-06	6.47e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—stomach cancer	6.25e-06	6.43e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—stomach cancer	6.15e-06	6.33e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—stomach cancer	6.12e-06	6.3e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK1—stomach cancer	6.12e-06	6.29e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGFR—stomach cancer	6.12e-06	6.29e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	6.08e-06	6.26e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	6.05e-06	6.22e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—stomach cancer	6.02e-06	6.2e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK1—stomach cancer	6.02e-06	6.19e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGFR—stomach cancer	6.02e-06	6.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK1—stomach cancer	5.99e-06	6.16e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGFR—stomach cancer	5.99e-06	6.16e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—stomach cancer	5.85e-06	6.02e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KRAS—stomach cancer	5.78e-06	5.94e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	5.76e-06	5.92e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KRAS—stomach cancer	5.69e-06	5.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—stomach cancer	5.68e-06	5.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KRAS—stomach cancer	5.66e-06	5.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—stomach cancer	5.6e-06	5.76e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HRAS—stomach cancer	5.59e-06	5.75e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	5.48e-06	5.63e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGFR—stomach cancer	5.48e-06	5.63e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—stomach cancer	5.35e-06	5.51e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—stomach cancer	5.31e-06	5.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	5.22e-06	5.37e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	5.2e-06	5.34e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KRAS—stomach cancer	5.17e-06	5.32e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—stomach cancer	5.14e-06	5.28e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—stomach cancer	5.05e-06	5.2e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—stomach cancer	5.03e-06	5.17e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HRAS—stomach cancer	4.91e-06	5.05e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HRAS—stomach cancer	4.83e-06	4.97e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HRAS—stomach cancer	4.81e-06	4.94e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	4.75e-06	4.89e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—stomach cancer	4.7e-06	4.84e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—stomach cancer	4.63e-06	4.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—stomach cancer	4.6e-06	4.73e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—stomach cancer	4.6e-06	4.73e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HRAS—stomach cancer	4.4e-06	4.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—stomach cancer	4.21e-06	4.33e-05	CbGpPWpGaD
